This inventor holds 3 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Abtis Co., Ltd., Sungkyunkwan University, Abtis Co., Ltd.. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 4 
2 out of 1,377 
1 out of 1 Years Active: 2024-2026
Title: Young Geun Lee: Innovator in Antibody Conjugation Technology
Introduction
Young Geun Lee is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of bioconjugation, particularly in the development of antibody-payload conjugates. With a total of two patents to his name, his work is paving the way for advancements in targeted therapies.
Latest Patents
Young Geun Lee's latest patents include a compound for the preparation of antibody-payload conjugates and the use thereof. This application relates to a novel linker designed for bioconjugation, which comprises two or more electrophilic carbon atoms of a carbonyl group and a click chemistry functional group. This innovative linker allows for the direct or indirect linking of compounds, peptides, or proteins to a desired target molecule through a substitution reaction. His second patent focuses on site-specific antibody conjugation and antibody-drug conjugates. This technology enables the labeling of specific sites on antibodies with a precise number of chemical functional groups or cargo moieties. The invention ensures high uniformity in antibody products while maintaining their functional integrity, including binding affinity and half-life. This groundbreaking technology is significant as it allows for site-specific labeling of antibodies without complicated processes.
Career Highlights
Throughout his career, Young Geun Lee has worked with reputable organizations such as Abtis Co., Ltd. and Sungkyunkwan University. His experience in these institutions has contributed to his expertise in the field of bioconjugation and antibody technology.
Collaborations
Young Geun Lee has collaborated with notable colleagues, including Ju Hwan Kim and Tae Jin Lee. These partnerships have further enhanced his research and development efforts in the field.
Conclusion
Young Geun Lee's innovative work in antibody conjugation technology is making a significant impact in the field of bioconjugation. His patents reflect a commitment to advancing targeted therapies, which could lead to improved treatment options in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile